-
ABOUT USHebei Guangxiang Pharmaceutical Co., Ltd. is specializing in the production of bulk pharmaceuticals, fine pharmaceuticals, intermediate compounds and biopharmaceutical preparations.
-
News CenterAt the forefront of corporate development, we champion the positive energy of the Four Pharmaceutical Companies: fulfilling our duties conscientiously, stepping up to the plate and taking proactive action, embracing new missions, and conducting effective new publicity. In doing so, we aim to enhance the overall competence of our employees, stimulate their enthusiasm, initiative, and creativity, and provide robust ideological guidance and powerful spiritual strength to drive the enterprise forward.
-
INNOVATIONDevelops fine, series, high-end bulk pharmaceutical intermediates and innovative bulk pharmaceutical intermediates with high added value to build variety competition advantages.
-
-
RECRUITGuangxiang has jointly established engineering laboratories, technology research centers and other high-level innovation platforms with CAS, Zhejiang University, Tianjin University and other universities.
-
CONTACTWith stable production, high-quality and reliable service, the company's products have been sold to more than 80 countries such as the United States, the United Kingdom, Germany and the Netherlands
Grand Commendation Conference Held for Advanced Collectives in Shijiazhuang Sihua Pharmaceutical Group’s Guangxiang Pharmaceutical Production-Boosting Campaign
Category:
TIME：2022-01-20
【SUMMARY】
1月3日，石家庄四药集团广祥制药提产攻坚行动先进集体表彰大会隆重召开
With unwavering resolve and vigorous momentum, we embark on a new journey, steadfastly pressing forward with relentless dedication and pioneering spirit. On January 3, as the rising sun bathed the Bohai New Area in brilliant light, 68 outstanding representatives from various production workshops and functional departments of Hebei Guangxiang Pharmaceutical Co., Ltd., a subsidiary of Shijiazhuang Sihua Pharmaceutical Group, wore expressions of pride and New Year’s joy. To the festive and uplifting strains of the “Step by Step Higher” melody, they gathered together with Qu Jiguang, Chairman of the Group’s Board of Directors; Wu Hengyao, President of the Group; Shi Jianhui, Secretary of the Group’s Party Committee; and Song Mingxia, Chairwoman of the Trade Union, to enthusiastically attend the “Recognition Conference for Advanced Collectives in the Production-Boosting Campaign at Guangxiang Pharmaceutical, Shijiazhuang Sihua Pharmaceutical Group.”
In the just-concluded year of 2021, all employees of Guangxiang Pharmaceutical Group worked in unison and with unwavering determination, overcoming numerous challenges and tirelessly pressing forward day and night for three consecutive months. As a result, three key performance indicators—yield, quality, and daily production output of the principal active pharmaceutical ingredient, caffeine—experienced substantial improvements, fully demonstrating the sense of responsibility and commitment of the Guangxiang team. This not only secured market share for the company but also earned widespread recognition and trust from our customers. To commend outstanding units and set exemplary models, and to ensure the comprehensive implementation of the Group’s and Guangxiang Pharmaceutical’s 2022 goals and tasks while taking production enhancement efforts to a new level, the Group has decided to recognize and reward 18 advanced workshops and departments, including Workshops 601, 602, and 603, as well as the Environmental Protection Workshop and the Power Workshop.
“The leadership has provided outstanding guidance, and our team’s relentless efforts have brought brilliant achievements. The remarkable results of our攻坚 action are attributable to the strong support of our leaders, the seamless collaboration among colleagues, and, above all, the unwavering dedication and continuous progress of our company’s exceptional team,” said Wang Caiyan, representative of the Environmental Protection Workshop, in her statement. Meanwhile, representatives from Workshops 601, 602, and 603—Teng Liqiang, Wu Zhanying, and Li Shuai, respectively—pledged in their remarks to redouble their efforts and continue making new contributions to the company’s development.
In his address, Cui Yongbin, Chairman of Guangxiang Pharmaceutical, stated that the company will continuously draw lessons from its攻坚 (hard-fought) initiatives, seize promising development opportunities, and meet new challenges with unwavering enthusiasm and high morale.
“When Guangxiang is strong, the Group is strong.” The recently concluded 2022 Policy and Target Launch Conference of Shijiazhuang Sihua Pharmaceutical Group has assigned Guangxiang Pharmaceutical an even more formidable development mandate, with each target carrying significant weight. In his concluding remarks at the awards ceremony, Qu Jiguang, Chairman of the Group’s Board of Directors, expressed high expectations for Guangxiang Pharmaceutical.
Chairman Qu Jiguang emphasized the following: First, we must seize development and market opportunities, maintain unwavering commitment and relentless effort, and forge ahead with unrelenting determination. With the spirit of striving for excellence in everything we do and never letting up once we have set our sights on a goal, we must leave no stone unturned and remain vigilant at every moment, ensuring that all tasks are firmly under our control and that Guangxiang Pharmaceutical achieves new and even greater breakthroughs in all areas of its work. Second, we must vigorously promote the model worker spirit, the labor spirit, and the craftsman spirit, and strive to build a high-caliber workforce. We must fully recognize the importance and urgency of talent development, closely monitor cutting-edge knowledge and technological advances in our industry and related sectors, and continuously broaden our technical horizons and enhance our skill levels. We should also refine our talent incentive policies to encourage more employees—especially young people—to pursue career growth through skill development, thereby truly cultivating a workforce that is idealistic and committed to core values, technically proficient and innovative, and willing to take responsibility and make selfless contributions.
The commendation conference generated a strong response at Guangxiang Pharmaceutical, a subsidiary of the Group. Employees unanimously pledged to carry forward the spirit of relentless striving—“the more arduous the challenges, the more we press ahead”—to fight continuously, keep pace with the times, and bravely shoulder the glorious mission of driving the enterprise’s innovative development. Upholding the ethos of “doing ten times as much as others when they do one, and a hundred times as much when they do ten,” they will strive to deliver outstanding results that satisfy the Group’s drive for high-quality growth and greet the successful convening of the 20th National Congress of the Communist Party of China with exemplary achievements.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
E-mail: hbgxzy@hebgxzy.com
Address: The west of Jingliu Road, lingang economic nad technological development zone, cangzhou city, Hebei province
Website
Official WeChat
e-Home
Business License
